In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence...
from NDTV News - World-news https://ift.tt/3gd4P7t
No comments:
Post a Comment